SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-020731
Filing Date
2022-08-04
Accepted
2022-08-03 17:56:43
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20220630.htm   iXBRL 10-Q 1074316
2 EX-10.1 cort63022ex101.htm EX-10.1 48535
3 EX-10.2 cort63022ex102.htm EX-10.2 45156
4 EX-31.1 cort63022ex311.htm EX-31.1 9530
5 EX-31.2 cort63022ex312.htm EX-31.2 9616
6 EX-32.1 cort63022ex321.htm EX-32.1 5191
7 EX-32.2 cort63022ex322.htm EX-32.2 5117
  Complete submission text file 0001628280-22-020731.txt   4536152

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20220630.xsd EX-101.SCH 27893
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20220630_cal.xml EX-101.CAL 61154
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20220630_def.xml EX-101.DEF 88275
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20220630_lab.xml EX-101.LAB 356663
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20220630_pre.xml EX-101.PRE 220247
52 EXTRACTED XBRL INSTANCE DOCUMENT cort-20220630_htm.xml XML 691619
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 221133961
SIC: 2834 Pharmaceutical Preparations